Outlook Therapeutics (OTLK)
$1.7 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
3 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Outlook Therapeutics, AI stock picks, stock alerts and much more.
OTLK AI Stock Analysis
AI stock analysis for OTLK is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Outlook Therapeutics (OTLK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
OTLK Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Outlook Therapeutics (OTLK), currently trading at $1.7, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About OTLK
-
Outlook Therapeutics, Inc.
-
Symbol
OTLK
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
40.2M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.34 1.9% |
6 |
 |
Inovio Pharmaceuticals INO |
$4.19 4.5% |
2 |
 |
Moderna MRNA |
$43.39 3.2% |
4 |
 |
Anavex Life Sciences AVXL |
$9.03 0.1% |
4 |
 |
BridgeBio Pharma BBIO |
$27.49 4% |
5 |
News
OTLK Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
LinkedIn Followers
Sign up to access
LinkedIn Employees
Sign up to access
Job Postings
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
OTLK Financials
OTLK Key Metrics
-
Total Revenue
$0
-
Net Income
$44.4M
-
Earnings per Share
$1.91
-
Free cash flow
-$19.5M
-
EBITDA
-$19.5M
-
EBITDA Ratio
0
-
Total Assets
$47.1M
OTLK 2-year Revenue & Income
OTLK 2-year Free Cash Flow
OTLK Technicals
OTLK SMA
OTLK RSI
FAQ
What's the current price of Outlook Therapeutics (OTLK) Stock?
The price of an Outlook Therapeutics (OTLK) share is $1.7.
What's the market cap of Outlook Therapeutics?
The current market cap of Outlook Therapeutics is 40.2M.
Should I buy or sell OTLK?
Outlook Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Outlook Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is Outlook Therapeutics a good investment?
The current analysis of Outlook Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Outlook Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Outlook Therapeutics (OTLK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Outlook Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Outlook Therapeutics (OTLK) that investors often compare it to?
Outlook Therapeutics (OTLK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Outlook Therapeutics' stock price in 2025?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Outlook Therapeutics' stock price to be around $1.64 in 2025. Starting from the current price of $1.7, this represents a 3.8% change in price, indicating a neutral outlook for the stock.
How to buy Outlook Therapeutics (OTLK) Stock?
Outlook Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Outlook Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.